NCT06651177 2026-03-05
TAB
University of Cincinnati
Phase 2 Recruiting
Clinical Trials
11 trialsNCT07451197 2026-03-05
Family-Focused Study to Support Medication for Opioid Use Disorder
University of Wisconsin, Madison
Phase NA Not yet recruiting
NCT07408193 2026-02-20
The Role of Coadministration of Lidocaine and Ketamine in Opioid-Refractory Chronic Cancer-Related Pain.
National and Kapodistrian University of Athens
Phase EARLY_PHASE1 Not yet recruiting
NCT06200181 2026-02-13
Effect of Olanzapine on Opioid Craving and Misuse Among Patients Receiving Opioids for Cancer-related Pain: A Pilot Double-Blind, Randomized Control Trial
M.D. Anderson Cancer Center
Phase 3 Recruiting
NCT04921787 2026-01-28
EXHITENTRE
Hennepin Healthcare Research Institute
Phase NA Active not recruiting
NCT04091009 2025-12-31
Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms
Massachusetts General Hospital
Phase 4 Withdrawn
NCT06001749 2025-12-16
Psilocybin in Cancer Pain Study
Dana-Farber Cancer Institute
Phase 2 Recruiting
NCT04345718 2025-12-09
EXHITENTRE
Hennepin Healthcare Research Institute
Phase 2/3 Completed
NCT04933084 2023-12-21
Pre-operative Education Modalities to Decrease Opioid Use
Benaroya Research Institute
Phase NA Unknown
NCT03469310 2021-05-11
Minimizing Narcotic Analgesics After Endocrine Surgery
DHR Health Institute for Research and Development
Phase 4 Completed
NCT01004393 2016-02-02
Methylnaltrexone for Opioid-induced Constipation in Cancer Patients
University of Vermont
Phase 2 Completed